Daily Anesthesiology Research Analysis
Three high-impact studies inform perioperative neuro–critical care: a meta-analysis of RCTs found no definitive neurological benefit of liberal (≥9 g/dL) versus restrictive (≥7 g/dL) transfusion after acute brain injury, an IPD meta-analysis suggests prolonged postcardiotomy VA-ECMO support may be justified beyond 6 days, and a prospective cohort links greater lifetime general anesthesia exposure with long-term cognitive decline. Together, they refine transfusion targets, ECMO duration decisions
Summary
Three high-impact studies inform perioperative neuro–critical care: a meta-analysis of RCTs found no definitive neurological benefit of liberal (≥9 g/dL) versus restrictive (≥7 g/dL) transfusion after acute brain injury, an IPD meta-analysis suggests prolonged postcardiotomy VA-ECMO support may be justified beyond 6 days, and a prospective cohort links greater lifetime general anesthesia exposure with long-term cognitive decline. Together, they refine transfusion targets, ECMO duration decisions, and perioperative cognitive risk counseling.
Research Themes
- Transfusion thresholds and neurological outcomes in acute brain injury
- Duration of venoarterial ECMO support after cardiac surgery
- Long-term cognitive effects of cumulative general anesthesia exposure
Selected Articles
1. Liberal vs. restrictive transfusion strategies for acute brain injury: a systematic review and frequentist-Bayesian meta-analysis.
Across 4 RCTs (n=1,853), liberal transfusion thresholds (hemoglobin ≥9 g/dL) did not significantly improve 180-day favorable neurological outcomes versus restrictive thresholds (≥7 g/dL). Frequentist, Bayesian, and trial sequential analyses showed that one large trial strongly influenced heterogeneity; sensitivity analyses excluding it suggested potential benefit for liberal strategies. The authors advocate subgroup-focused research to enable individualized transfusion targets.
Impact: This study synthesizes the best randomized evidence on transfusion thresholds in acute brain injury using complementary analytic frameworks, addressing a longstanding clinical controversy with direct implications for neuro–critical care practice.
Clinical Implications: Do not universally adopt a liberal hemoglobin threshold (≥9 g/dL) for ABI; a restrictive threshold (≥7 g/dL) remains reasonable for most patients. Consider individualized strategies guided by physiology (e.g., brain tissue oxygenation, anemia severity, ongoing bleeding) while awaiting subgroup-specific RCTs.
Key Findings
- Included 4 RCTs (N=1,853): pooled RR for favorable neurological outcome with liberal vs restrictive transfusion was 0.84 (95% CI 0.65–1.09).
- Frequentist, Bayesian, and trial sequential analyses demonstrated substantial influence of a single trial on heterogeneity and effect size.
- Sensitivity analyses excluding the influential trial and restricting to low risk-of-bias studies suggested possible benefit of liberal transfusion.
Methodological Strengths
- Systematic review of randomized controlled trials with comprehensive database and registry searches.
- Use of frequentist, Bayesian, and trial sequential analyses to test robustness and information size sufficiency.
Limitations
- Only four RCTs with heterogeneity; overall effect heavily influenced by one trial.
- Potential variations in transfusion protocols, co-interventions, and ABI etiologies across studies limit generalizability and subgroup inference.
Future Directions: Conduct adequately powered, physiology-guided RCTs to identify subgroups (e.g., impaired brain oxygenation, severe anemia, ongoing bleeding) who may benefit from higher hemoglobin thresholds; consider individual patient data meta-analyses.
PURPOSE: To determine whether a liberal transfusion strategy (≥ 9 g/dL) improves neurological outcomes in adults with acute brain injury (ABI). METHOD: We systematically searched MEDLINE, EMBASE, the Cochrane Library, and trial registries for randomized controlled trials comparing liberal (≥ 9 g/dL) vs. restrictive (≥ 7 g/dL) transfusion in adults with ABI (traumatic brain injury, subarachnoid hemorrhage, intracranial hemorrhage) and Glasgow Coma Scale ≤ 13. Frequentist, Bayesian, and trial sequential analyses were used. The primary outcome was favorable neurological status at 180 days. RESULTS: Four randomized controlled trials (N = 1853; 922 liberal, 931 restrictive) were included. The pooled frequentist risk ratio (RR) for favorable neurological outcome was 0.84 (95% CI 0.65-1.09; I CONCLUSIONS: This review did not provide definitive evidence of a neurological benefit from liberal transfusion strategies in acute brain injury. Both frequentist and Bayesian analyses highlight the influence of a single trial on the overall effect estimate and heterogeneity. However, sensitivity analyses excluding this trial and focusing on studies with low risk of bias suggested that liberal transfusion strategies could improve neurological outcomes. Future research should focus on identifying patient subgroups most likely to benefit, guiding a more individualized approach.
2. How Long Should Patients Be Treated With Postcardiotomy Venoarterial Extracorporeal Membrane Oxygenation? Individual Patient Data Pooled Analysis.
An individual patient data meta-analysis (n=1,267 across 25 centers) found the lowest in-hospital mortality with 3–6 days of VA-ECMO after cardiac surgery, and adjusted analyses showed no significant mortality increase with support beyond 6 days up to 20 days. These findings support not imposing arbitrary time limits and justify continued support when clinical trajectory is favorable.
Impact: Provides the most granular pooled evidence to date on ECMO duration after cardiac surgery, directly informing bedside decisions about continuation versus withdrawal of support.
Clinical Implications: Avoid fixed time limits for VA-ECMO cessation purely based on duration; decisions should integrate patient trajectory, recovery markers, and risk profiles. These data support continued support beyond 6 days when there is potential for recovery.
Key Findings
- IPD meta-analysis of 1,267 postcardiotomy VA-ECMO patients from 10 studies and 25 hospitals.
- Lowest in-hospital mortality observed with 3–6 days of ECMO support.
- Adjusted multilevel mixed-effects modeling showed no significant increase in in-hospital mortality with ECMO duration >6 to 20 days.
Methodological Strengths
- Individual patient data pooled analysis enabling risk-adjusted, center-clustered modeling.
- Multicenter dataset spanning 25 hospitals increases generalizability.
Limitations
- Retrospective source studies; residual confounding and selection biases remain possible.
- Analyses limited by variables known at ECMO initiation; evolving clinical course and decision factors may be unmeasured.
Future Directions: Prospective registries capturing time-varying physiology and decision rationales during ECMO; randomized or adaptive trials addressing weaning strategies and duration thresholds.
OBJECTIVES: To investigate the optimal duration of venoarterial extracorporeal membrane oxygenation (ECMO) for cardiogenic shock refractory to medical therapies after cardiac surgery and whether its prolonged use is justified. DATA SOURCES: Previously published articles on postcardiotomy venoarterial ECMO. STUDY SELECTION: Articles reporting on the early outcome after postcardiotomy venoarterial ECMO in adult patients were identified through a systematic review of the literature. DATA EXTRACTION: Data on prespecified patients' characteristics, operative variables, and outcomes were provided by the authors of previous studies on this topic. DATA SYNTHESIS: Individual data of 1267 patients treated at 25 hospitals from ten studies were included in this meta-analysis. In-hospital mortality rates were lowest among patients treated 3-6 days with venoarterial ECMO. Multilevel mixed-effects logistic regression considering the cluster effect of the participating hospitals adjusted for individual patient's risk profile and operative variables showed that the risk in-hospital mortality did not significantly increase in patients treated more than 6 days up to 20 days. CONCLUSIONS: The present study demonstrated that prolonged venoarterial ECMO support after adult cardiac surgery may be justified. However, the analysis was limited by the knowledge of only those circumstances known at the start of ECMO.
3. Anaesthesia as a risk factor for long-term cognitive decline: Results of the prospective MAAS cohort study.
In a 12-year prospective cohort (n=1,823) with repeated cognitive testing, greater baseline cumulative exposure time to general anesthesia was independently associated with worse trajectories in executive function (CST), selective attention/mental speed (Stroop), and information processing speed (LDST). Age and education remained dominant contributors, while hypertension, diabetes, and smoking also adversely affected cognitive domains.
Impact: This large, long-term cohort contributes rigorous evidence to a debated question, quantifying the association between cumulative anesthesia exposure and domain-specific cognitive decline beyond demographic and health risk factors.
Clinical Implications: Include potential long-term cognitive risks in shared decision-making for patients requiring multiple surgeries; minimize anesthesia exposure where feasible, optimize vascular risk factors (hypertension, diabetes, smoking), and consider cognitive monitoring in high-risk individuals.
Key Findings
- Longer cumulative time under general anesthesia at baseline predicted worse longitudinal performance in executive function (CST, P<0.05), attention/mental speed (Stroop, P<0.001), and processing speed (LDST, P<0.005).
- Age and education were the strongest determinants of lifetime cognitive decline; hypertension, diabetes, and smoking also had adverse associations.
- Prospective design with three serial assessments over 12 years in 1,823 adults enhances causal inference compared with cross-sectional studies.
Methodological Strengths
- Prospective longitudinal cohort with repeated cognitive assessments across multiple domains.
- Linear mixed modeling adjusting for demographic, lifestyle, and health-related confounders.
Limitations
- Observational design with potential residual confounding; anesthesia exposure quantified as total time at baseline without detailed anesthetic agents/dose.
- Surgical pathology and perioperative factors may contribute to cognitive change and are difficult to fully disentangle.
Future Directions: Integrate granular anesthetic exposure metrics (agents, depth, burst suppression) and perioperative complications; emulate target trials to clarify causality; test mitigation strategies (depth-guided anesthesia, neuroprotective protocols).
BACKGROUND: There are concerns whether (repeated) exposure to general anaesthesia is associated with long-term cognitive decline. OBJECTIVE: We investigated the potential, negative relationship between total exposure to surgery under general anaesthesia and its impact on long-term cognitive development. DESIGN: A prospective longitudinal cohort study. SETTING: The Netherlands. PARTICIPANTS: 1823 Adults, aged 25-84 with normal cognitive functioning on inclusion with three serial cognitive assessments between 1995 and 2008, with comprehensive documentation on demographic, lifestyle, and health factors. MAIN OUTCOME MEASURES: The primary outcomes were test scores in the cognitive domains of learning and memory, executive function, selective attention, mental speed, and information processing speed. Linear mixed models were used to analyse the effects of the estimated total time under general anaesthesia at baseline on cognitive development during a 12-year follow-up period. RESULTS: When adjusting for demographic and systemic health-related factors, prolonged exposure to surgery under general anaesthesia (measured in total baseline minutes) negatively affected three cognitive domains. These included the CST (executive functioning, P < 0.05), Stroop (selective attention and mental speed, P < 0.001) and LDST (information processing speed, P < 0.005). Age and education were the primary factors impacting lifetime cognitive decline. Hypertension, diabetes, and smoking negatively affected various cognitive domains. CONCLUSION: Increased exposure to surgery under general anaesthesia independently contributes to long-term cognitive decline. Demographic variables and health-related factors are key contributors to accelerated cognitive decline over an individual's lifetime.